Skip to main content

Table 3 Other parameters of clinical outcome

From: Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study

 

Control

Exercise

Exercise + Diet

Before

After

p-value

Before

After

p-value

Before

After

p-value

Arms Extensors (N)

105,13 ± 46,27

107 ± 103,21

0,8125

46,11 ± 84,42

55,36 ± 76,91

0,3125

96,86 ± 96,02

87,4 ± 101,1

0,4609

Arms Flexors (N)

104,48 ± 106,84

123,38 ± 80,9

0,5469

74,8 ± 79,88

64,74 ± 59,54

0,25

97,65 ± 79,4

89,03 ± 78,78

0,1953

Legs Extensors (N)

164,23 ± 111,47

185,95 ± 120,07

0,5469

136,62 ± 186,13

148,5 ± 81,51

0,3125

179 ± 199,61

152,86 ± 248,1

0,9453

Legs Flexors (N)

120,87 ± 85,22

94,88 ± 74,49

0,9375

80,62 ± 79,91

55,5 ± 47,26

0,2109

67,7 ± 33,84

79,73 ± 60,5

0,3125

CK (U/L)

280 ± 257

279 ± 284

0,2383

258 ± 262

371 ± 213

0,4131

272,5 ± 218

255 ± 104

0,1406

LDH (U/L)

322 ± 209

325 ± 215

0,1367

320 ± 218

320 ± 257

0,2012

303 ± 278

261,5 ± 240

0,0469

6MWT (m)

404 ± 93

412 ± 127

0,4258

425 ± 151

420 ± 152

0,166

416,8 ± 129

409 ± 119,2

1

VC (%)

70 ± 33

71 ± 31

0,1797

71 ± 42

71 ± 48,5

0,9844

75 ± 42

89,5 ± 44

0,0625

FEV1 (%)

70 ± 33

71 ± 38

0,3789

71 ± 42

72,4 ± 39,5

0,4844

66,5 ± 53

85 ± 49

0,0391

  1. Data are expressed as median ± interquartile range before and after each intervention period
  2. 6MWT maximum walking distance measured by the 6 min walking test
  3. VC vital capacity, FEV1 forced expiratory volume in 1 s